Clinical trial
Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor…
NCT00426972 · Renovo, Industry · Completed
Key facts
| NCT number | NCT00426972 |
|---|---|
| Title | Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites |
| Official title | A Double Blind, Placebo Controlled Trial to Investigate the Efficacy of Zesteem (Estradiol) in Accelerating the Healing of Split Thickness Skin Graft Donor Sites. |
| Lead sponsor | Renovo, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Burn, Trauma, Varicose Ulcer |
| Intervention type | Drug |
| Interventions | estradiol (Zesteem) |
| Enrollment | 148 |
| Start date | Jan 1, 2007 |
| Primary completion | Jul 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jan 25, 2007 |
| Last update posted | Aug 28, 2009 |
| Countries | Germany, Latvia, Russia, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: